Business Description
AVITA Medical Inc
NAICS : 339112
SIC : 5047
ISIN : US0537921076
Share Class Description:
RCEL: ADRDescription
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.1 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.87 | |||||
| Debt-to-EBITDA | -1.26 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -1.19 | |||||
| Beneish M-Score | -3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 41.2 | |||||
| 3-Year EBITDA Growth Rate | 13.5 | |||||
| 3-Year EPS without NRI Growth Rate | 12.2 | |||||
| 3-Year FCF Growth Rate | -10.2 | |||||
| 3-Year Book Growth Rate | -17.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 40.55 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.67 | |||||
| 9-Day RSI | 10.09 | |||||
| 14-Day RSI | 15.43 | |||||
| 6-1 Month Momentum % | 59.44 | |||||
| 12-1 Month Momentum % | 10.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.88 | |||||
| Quick Ratio | 7.46 | |||||
| Cash Ratio | 6.75 | |||||
| Days Inventory | 168.58 | |||||
| Days Sales Outstanding | 39.76 | |||||
| Days Payable | 163.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 | |||||
| Shareholder Yield % | -5.12 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.48 | |||||
| Operating Margin % | -85.07 | |||||
| Net Margin % | -70.56 | |||||
| FCF Margin % | -78.69 | |||||
| ROE % | -51.58 | |||||
| ROA % | -37.65 | |||||
| ROIC % | -356.34 | |||||
| ROC (Joel Greenblatt) % | -832.41 | |||||
| ROCE % | -41.79 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.37 | |||||
| PB Ratio | 4.52 | |||||
| Price-to-Tangible-Book | 4.57 | |||||
| EV-to-EBIT | -5.13 | |||||
| EV-to-EBITDA | -5.23 | |||||
| EV-to-Revenue | 3.5 | |||||
| EV-to-Forward-Revenue | 1.95 | |||||
| EV-to-FCF | -4.45 | |||||
| Price-to-Net-Current-Asset-Value | 5.37 | |||||
| Price-to-Net-Cash | 8.39 | |||||
| Earnings Yield (Greenblatt) % | -19.49 | |||||
| FCF Yield % | -17.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AVITA Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 50.143 | ||
| EPS (TTM) ($) | -1.4 | ||
| Beta | 2.06 | ||
| Volatility % | 86.85 | ||
| 14-Day RSI | 15.43 | ||
| 14-Day ATR ($) | 0.875273 | ||
| 20-Day SMA ($) | 13.36575 | ||
| 12-1 Month Momentum % | 10.16 | ||
| 52-Week Range ($) | 8.5 - 21.704 | ||
| Shares Outstanding (Mil) | 25.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AVITA Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AVITA Medical Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AVITA Medical Inc Frequently Asked Questions
What is AVITA Medical Inc(RCEL)'s stock price today?
The current price of RCEL is $8.64. The 52 week high of RCEL is $21.70 and 52 week low is $8.50.
When is next earnings date of AVITA Medical Inc(RCEL)?
The next earnings date of AVITA Medical Inc(RCEL) is 2024-05-13.
Does AVITA Medical Inc(RCEL) pay dividends? If so, how much?
AVITA Medical Inc(RCEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers